Two Onc Docs

This week’s episode will be focusing on inherited platelet disorders. We will go over the important details on the roles of platelets, the  diagnosis of inherited platelet disorders through aggregation studies, as well as the treatment of these disorders.

This week’s episode will be focusing on one more of the myeloproliferative neoplasms, Primary Myelofibrosis (PMF). We will go over important details on the diagnosis, risk stratification  and treatment options.

This week’s episode will be focusing on Esophageal and Gastrosophageal Junction (GEJ) Cancers. We will go over high yield details on the risk factors, diagnosis, and treatment for both localized and metastatic esophageal cancer.

This week’s episode is part 2 of our series in honor of Sarcoma Awareness Month. We will be focusing on Bone sarcomas. We will go over the important details on diagnosis, staging, subtypes and treatment of a few highly testable bone sarcomas. 

Since July is Sarcoma Awareness Month, we are starting a 2-part series on sarcomas. This week’s episode will be focusing on soft tissue sarcomas. We will go over the important details on the diagnosis, subtypes and treatment of a few of the highly testable soft tissue sarcomas.

This week is the final episode of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of localized ER+/HER-2- breast cancer and covering an oral abstract from the ASCO 2023 annual meeting,  the NATALEE Trial. We also cover some more statistics pearls that are important in oncology trials.

This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting,  the CONTACT03 Trial. We also cover subgroup analysis interpretation.

This week’s episode is part 1 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of locally advanced rectal cancer and covering a plenary session abstract from the ASCO 2023 annual meeting,  the PROSPECT Trial. We also cover the concept of non-inferiority trials.